Matches in SemOpenAlex for { <https://semopenalex.org/work/W3145382012> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W3145382012 endingPage "1194" @default.
- W3145382012 startingPage "1184" @default.
- W3145382012 abstract "Abstract Purpose This article reviews the efficacy and safety of revefenacin, the first once-daily, long-acting muscarinic antagonist, when delivered via a standard jet nebulizer in patients with chronic obstructive pulmonary disease (COPD). Summary Revefenacin 175 µg is indicated for the maintenance treatment of patients with moderate to very severe COPD. Preclinical studies showed that revefenacin is a potent and selective antagonist with similar affinity for the different subtypes of muscarinic receptors (M1-M5). Furthermore, prevention of methacholine- and acetylcholine-induced bronchoconstrictive effects was dose dependent and lasted longer than 24 hours, demonstrating a long duration of action. In phase 2 and 3 trials, treatment with revefenacin was demonstrated to result in statistical improvements in pulmonary function (≥100 mL, P < 0.05) vs placebo, including among patients with markers of more severe disease and those who received concomitant long-acting β-agonists or long-acting β-agonists together with inhaled corticosteroids. Revefenacin was also demonstrated to have efficacy similar to that of tiotropium. The clinical trial findings indicated no significant difference between revefenacin and tiotropium with regard to rates of adverse events. Overall, revefenacin was well tolerated, with COPD worsening/exacerbation, dyspnea, headache, and cough among the most common adverse events noted in the clinical trials. Conclusions Revefenacin treatment delivered via nebulization led to improvements in lung function in patients with COPD. It was also generally well tolerated, with no major safety concerns. Revefenacin provides a viable treatment option for patients with COPD and may be a suitable alternative for those with conditions that may impair proper use of traditional handheld inhalers." @default.
- W3145382012 created "2021-04-13" @default.
- W3145382012 creator A5027924439 @default.
- W3145382012 date "2021-04-04" @default.
- W3145382012 modified "2023-10-16" @default.
- W3145382012 title "Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease" @default.
- W3145382012 cites W1973324320 @default.
- W3145382012 cites W2121421664 @default.
- W3145382012 cites W2137670731 @default.
- W3145382012 cites W2235318197 @default.
- W3145382012 cites W2533530701 @default.
- W3145382012 cites W2610673579 @default.
- W3145382012 cites W2762828327 @default.
- W3145382012 cites W2766794969 @default.
- W3145382012 cites W2800406733 @default.
- W3145382012 cites W2946624880 @default.
- W3145382012 cites W2947307811 @default.
- W3145382012 cites W2970217528 @default.
- W3145382012 cites W2978122528 @default.
- W3145382012 cites W2982651237 @default.
- W3145382012 cites W2994914468 @default.
- W3145382012 cites W3008177675 @default.
- W3145382012 cites W3019445892 @default.
- W3145382012 cites W3024372630 @default.
- W3145382012 doi "https://doi.org/10.1093/ajhp/zxab154" @default.
- W3145382012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8083528" @default.
- W3145382012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33821890" @default.
- W3145382012 hasPublicationYear "2021" @default.
- W3145382012 type Work @default.
- W3145382012 sameAs 3145382012 @default.
- W3145382012 citedByCount "1" @default.
- W3145382012 countsByYear W31453820122023 @default.
- W3145382012 crossrefType "journal-article" @default.
- W3145382012 hasAuthorship W3145382012A5027924439 @default.
- W3145382012 hasBestOaLocation W31453820121 @default.
- W3145382012 hasConcept C126322002 @default.
- W3145382012 hasConcept C142724271 @default.
- W3145382012 hasConcept C170493617 @default.
- W3145382012 hasConcept C197934379 @default.
- W3145382012 hasConcept C204787440 @default.
- W3145382012 hasConcept C27081682 @default.
- W3145382012 hasConcept C2776178081 @default.
- W3145382012 hasConcept C2776723954 @default.
- W3145382012 hasConcept C2776780178 @default.
- W3145382012 hasConcept C2776885963 @default.
- W3145382012 hasConcept C2777014857 @default.
- W3145382012 hasConcept C2777714996 @default.
- W3145382012 hasConcept C2779384505 @default.
- W3145382012 hasConcept C2781260171 @default.
- W3145382012 hasConcept C33789571 @default.
- W3145382012 hasConcept C42219234 @default.
- W3145382012 hasConcept C535046627 @default.
- W3145382012 hasConcept C71924100 @default.
- W3145382012 hasConcept C75603125 @default.
- W3145382012 hasConceptScore W3145382012C126322002 @default.
- W3145382012 hasConceptScore W3145382012C142724271 @default.
- W3145382012 hasConceptScore W3145382012C170493617 @default.
- W3145382012 hasConceptScore W3145382012C197934379 @default.
- W3145382012 hasConceptScore W3145382012C204787440 @default.
- W3145382012 hasConceptScore W3145382012C27081682 @default.
- W3145382012 hasConceptScore W3145382012C2776178081 @default.
- W3145382012 hasConceptScore W3145382012C2776723954 @default.
- W3145382012 hasConceptScore W3145382012C2776780178 @default.
- W3145382012 hasConceptScore W3145382012C2776885963 @default.
- W3145382012 hasConceptScore W3145382012C2777014857 @default.
- W3145382012 hasConceptScore W3145382012C2777714996 @default.
- W3145382012 hasConceptScore W3145382012C2779384505 @default.
- W3145382012 hasConceptScore W3145382012C2781260171 @default.
- W3145382012 hasConceptScore W3145382012C33789571 @default.
- W3145382012 hasConceptScore W3145382012C42219234 @default.
- W3145382012 hasConceptScore W3145382012C535046627 @default.
- W3145382012 hasConceptScore W3145382012C71924100 @default.
- W3145382012 hasConceptScore W3145382012C75603125 @default.
- W3145382012 hasIssue "13" @default.
- W3145382012 hasLocation W31453820121 @default.
- W3145382012 hasLocation W31453820122 @default.
- W3145382012 hasOpenAccess W3145382012 @default.
- W3145382012 hasPrimaryLocation W31453820121 @default.
- W3145382012 hasRelatedWork W1691176284 @default.
- W3145382012 hasRelatedWork W2003254263 @default.
- W3145382012 hasRelatedWork W2065417419 @default.
- W3145382012 hasRelatedWork W2081320142 @default.
- W3145382012 hasRelatedWork W2137670731 @default.
- W3145382012 hasRelatedWork W2330059308 @default.
- W3145382012 hasRelatedWork W2399966830 @default.
- W3145382012 hasRelatedWork W2462985432 @default.
- W3145382012 hasRelatedWork W3145382012 @default.
- W3145382012 hasRelatedWork W4200357806 @default.
- W3145382012 hasVolume "78" @default.
- W3145382012 isParatext "false" @default.
- W3145382012 isRetracted "false" @default.
- W3145382012 magId "3145382012" @default.
- W3145382012 workType "article" @default.